Bevacizumab, Cetuximab Have Similar Survival Benefits in CRCBevacizumab, Cetuximab Have Similar Survival Benefits in CRC

Adding either bevacizumab or cetuximab to chemotherapy yielded equal benefits in metastatic colorectal cancer (CRC). Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news